Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox to $122 from $132 and keeps an Underweight rating on the shares. The analyst believes the macro backdrop and/or relative valuations “present a difficult investment landscape” within U.S. consumer staples heading into the Q2 reports. Food valuations appear attractive, though the fundamentals largely do not, the analyst tells investors in a research note. The firm says it “feels difficult to find pockets of meaningful upside potential at either end of the spectrum right now.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $145 from $150 at Citi
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Clorox initiated with an Underperform at Exane BNP Paribas
- Argus looking for more favorable entry point in Clorox
- Rising Digital Threats Make CyberArk Software Stock (NASDAQ:CYBR) Almost a No-Brainer